RXO (NYSE: RXO) reported Q4 EPS of $0.28, $0.02 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.14 billion.

For earnings history and earnings-related data on RXO (RXO) click here.